These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 15103005)
21. [A case of dihydropyrimidine dehydrogenase (DPD) deficiency with severe side effects from UFT/Uzel administration]. Kai K; Endo Y; Yoshida K; Morikawa T; Nobuhisa T; Watanabe T; Matsumoto Y; Yamada T; Doi Y; Nakashima A; Nagahiro W; Ishizuka S; Sato S; Nakashima A; Nabeyama A Gan To Kagaku Ryoho; 2008 Feb; 35(2):339-41. PubMed ID: 18281779 [TBL] [Abstract][Full Text] [Related]
22. A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study. Tsuchiya T; Kamohara R; Muraoka M; Nagayasu T; Saeki S; Takenoyama M; Suzuki M; Inada K; Tokunaga S; Hayashi T; Urabe S; Koga T; Akamine S; Sugio K BMC Cancer; 2020 Dec; 20(1):1192. PubMed ID: 33276755 [TBL] [Abstract][Full Text] [Related]
23. [Chemotherapy with cisplatin and daily administration of UFT for unresectable non-small cell lung cancer]. Takanashi N; Hara N; Ichinose Y; Asoh H; Yano T; Yokoyama H; Miura T; Matsuoka Y; Tayama K; Ohta M Gan To Kagaku Ryoho; 1993 May; 20(7):921-7. PubMed ID: 8387761 [TBL] [Abstract][Full Text] [Related]
24. [A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer]. Fukushima M; Tsushima T; Ito H; Fukuda Y; Maruyama A; Fujita H; Yagihashi N; Tsuge T; Ishioka T; Kudo T; Kishibe S; Sato T; Machida S; Kogawa R; Takashima K; Koie H; Fujita K Gan To Kagaku Ryoho; 1996 Feb; 23(3):303-9. PubMed ID: 8712823 [TBL] [Abstract][Full Text] [Related]
25. Chemotherapy as adjuvant therapy for completely resected non-small-cell lung cancer: have we made progress? Feld R J Clin Oncol; 1996 Apr; 14(4):1045-7. PubMed ID: 8648355 [No Abstract] [Full Text] [Related]
26. [A case of pulmonary metastases of breast cancer responding remarkably to combined chemotherapy with 5-fluorouracil and low-dose cisplatin]. Iwamoto M; Niiya F; Ikeda S; Nagata S; Odou E; Hayabuchi N Gan To Kagaku Ryoho; 2000 Dec; 27(14):2239-42. PubMed ID: 11142169 [TBL] [Abstract][Full Text] [Related]
27. Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer. Gemma A; Kudoh S; Yoshimura A; Ono Y; Takenaka K; Hayashihara K; Hino M; Shibuya M; Niitani H Anticancer Res; 1995; 15(6B):2691-5. PubMed ID: 8669849 [TBL] [Abstract][Full Text] [Related]
28. [A phase II study of UFT in non-small cell lung cancer]. Shimizu E; Kimura K; Sone S; Inoue I; Nakamura Y; Noda Y; Hojo F; Yagi M; Nakanishi S; Yamasaki K Gan To Kagaku Ryoho; 1986 Oct; 13(10):2970-3. PubMed ID: 3021068 [TBL] [Abstract][Full Text] [Related]
29. [Results of a Special Drug Use-Results Survey on Compliance to Tegafur/Uracil(UFT)Adjuvant Chemotherapy for Non-Small Cell Lung Cancer]. Koyama T; Funato Y; Yamaguchi Y; Oda M; Ito K Gan To Kagaku Ryoho; 2015 Aug; 42(8):973-80. PubMed ID: 26321712 [TBL] [Abstract][Full Text] [Related]
30. [Combination chemotherapy with continuous infusion of low-dose cisplatin and UFT for advanced non-small cell lung cancer]. Seike M; Andoh M; Hasegawa K; Sakonji M; Tsuboi E Gan To Kagaku Ryoho; 1998 Aug; 25(10):1539-42. PubMed ID: 9725046 [TBL] [Abstract][Full Text] [Related]
31. [5-FU concentration in blood and tissue of patients with primary lung cancer after oral administration of UFT]. Oiwa T; Saito H Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):525-30. PubMed ID: 3082289 [TBL] [Abstract][Full Text] [Related]
32. [5-FU concentration in tissues of gastric cancer patients with preoperative administration of UFT--especially in comparison with FT-207]. Takeshita M; Ishikawa H; Seki M; Ikeya T; Miyamoto Y; Izuo M; Tozuka S; Usui R; Kaneko H Gan No Rinsho; 1985 Oct; 31(13):1697-703. PubMed ID: 3935831 [TBL] [Abstract][Full Text] [Related]
33. UFT: biochemical modulation for 5-fluorouracil (5-FU). Taguchi T Chin Med J (Engl); 1997 Apr; 110(4):294-6. PubMed ID: 9594232 [No Abstract] [Full Text] [Related]
34. Adjuvant chemotherapy for lung cancer--a new standard of care. Blum RH N Engl J Med; 2004 Jan; 350(4):404-5. PubMed ID: 14736933 [No Abstract] [Full Text] [Related]
35. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer. Hoff PM; Pazdur R; Benner SE; Canetta R Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235 [TBL] [Abstract][Full Text] [Related]
36. [Pharmacokinetics of S-1]. Hirata K; Horikoshi N; Tominaga K; Sohma K; Yamaguchi K; Okazaki M; Furuhata T; Sasaki K; Nakano Y; Ishizuka H; Yamada Y; Uno S; Taguchi T; Yamamitsu S; Shirasaka T Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():27-35. PubMed ID: 16897969 [TBL] [Abstract][Full Text] [Related]
37. [Fundamental studies on the surgical adjuvant chemotherapy to support the clinical efficacies]. Tsukagoshi S Gan To Kagaku Ryoho; 1997 Aug; 24(10):1213-20. PubMed ID: 9279339 [TBL] [Abstract][Full Text] [Related]
38. [A case of unresectable colon cancer responding to oral leucovorin+oral tegafur/uracil]. Saito N; Ohata M; Ishii H; Ohori M; Tokura Y; Maruyama M; Furukawa T; Sato H Gan To Kagaku Ryoho; 2007 Aug; 34(8):1287-90. PubMed ID: 17687215 [TBL] [Abstract][Full Text] [Related]
39. Dihydropyrimidine dehydrogenase activity during long-term adjuvant treatment with oral uracil and tegafur for colorectal cancer. Sadahiro S; Suzuki T; Maeda Y; Ishikawa K; Tanaka Y; Yasuda S; Kamijo A; Makuuchi H; Murayama C Chemotherapy; 2007; 53(6):442-5. PubMed ID: 17952005 [TBL] [Abstract][Full Text] [Related]